Merck (MRK) stock is in focus as the FDA approves a label expansion for the company's once-yearly parasiticide treatment.

Terumo Blood and Cell Technologies has entered a new collaboration with Taiwan Bio Therapeutics to transition regulatory T‑cell manufacturing onto the automated Quantum Flex platform, marking a shift ...

BrownCarGuy Therapy Session – LIVE! Welcome to spontaneous live edition of BrownCarGuy Therapy Sessions -with Reza Adil and David from Huxley Automotive - filmed initially on Instagram Live while I ...

Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...

Taiwan Bio will leverage the Quantum Flex™ Cell Expansion System 3-in-1 workflow beyond CAR-T to support development ...

Shares of AbbVie ABBV fell 5.2% on Wednesday, wiping out more than $20 billion in market value. This selloff comes as ...

March 21, 2026: Our weekly roundup of the latest science in the news, as well as a few fascinating articles to keep you ...

Encompass Health Corporation EHC recently disclosed plans to construct a new freestanding inpatient rehabilitation hospital in Bear, DE. The facility will be equipped with 40 beds.  The hospital ...

Earlier in March 2026, Vertex Pharmaceuticals reported positive pre-specified Week 36 interim Phase 3 RAINIER data for ...

Through the remarkable efforts of NASA and the National Library of Medicine, we now understand that the human brain a ...

Cybersecurity has evolved from a secondary software concern to a core design requirement in connected medical devices. The ...